Heartware International Inc. (HTWR)
-NasdaqGS | Prev Close: | 95.05 |
|---|
| Open: | N/A |
|---|
| Bid: | 93.35 x 100 |
|---|
| Ask: | 118.08 x 100 |
|---|
| 1y Target Est: | 102.80 |
|---|
| Beta: | -0.19 |
|---|
| Next Earnings Date: | 4-Aug-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 74.77 - 99.68 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 247,239 |
|---|
| Market Cap: | 1.58B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -5.59 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- HeartWare Beating Away, Pulse Still Strongat Forbes(Tue, May 21)
- Volcano Product Launch at EuroPCRZacks(Tue, May 21)
- THOR Downgraded to UnderperformZacks(Tue, May 21)
- Bull Of The Day: Heartwareat Seeking Alpha(Tue, May 21)
- Zacks Bull and Bear of the Day Highlights: Heartware International, Jive Software, JPMorgan Chase, American International Group and Bank of AmericaZacks(Tue, May 21)
- Bull of the Day: HeartWare (HTWR)Zacks(Tue, May 21)
- HeartWare International's CEO Presents at UBS Global Healthcare Conference Transcriptat Seeking Alpha(Mon, May 20)
- FDA Nod for Thoratec ControllerZacks(Mon, May 20)
- PKI Downgraded to UnderperformZacks(Mon, May 20)
- Medical Products Companies, Particularly Those Aimed at Surgical Procedures, Generating Substantial Free Cash and Showing High Returns on CapitalWall Street Transcript(Fri, May 17)
- Heartware International's CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)at Seeking Alpha(Thu, May 16)
- HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be WebcastPR Newswire(Thu, May 16)
- Vital Therapies, Inc. Adds Two New Board MembersMarketwired(Thu, May 16)
- Fresenius Teams with ApolloMedZacks(Wed, May 15)
- HMA Downgraded to UnderperformZacks(Tue, May 14)
Comparison
| Symbol | % Chg | Mkt Cap |
|---|
| HTWR | 0.00% | 1.58B |
| BAX | 0.00% | 39.58B |
| COV | 0.00% | 30.96B |
| CSRT.L | 0.58% | 224.39M |
| BDX | 0.00% | 19.62B |
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 11.78 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -3.20 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.80 |
|---|
| Mean Recommendation*: | 2.4 |
|---|
| PEG Ratio (5 yr expected): | -1.99 |
|---|
Business Summary
HeartWare International, Inc., a medical device company, engages in developing and manufacturing miniaturized implantable heart pumps or ventricular assist devices (VAD) for the treatment of advanced heart failure in the United States and internat...
View More